Daniel Karlin

Chief Medical Officer at Definium Therapeutics Inc.

Sits on 1 board. Last updated September 30, 2026

Time on boards

Boards served
1
Current seats
1
Board service
1 month
Director since
2026

1 month of board service in total across 1 board, counting each seat separately. Longest: Definium Therapeutics Inc., 1 month.

Definium Therapeutics Inc. Director · Chief Medical Officer
1 month · Since 2026

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Date Company Transaction Shares Price Value
Sep 25, 2026 Definium Therapeutics Inc. Open-market sale −10,853 $36.57 $396,894
Sep 14, 2026 Definium Therapeutics Inc. Grant or award +200,000 — —
Aug 12, 2026 Definium Therapeutics Inc. Grant or award +100,000 — —

Questions about Daniel Karlin

What boards is Daniel Karlin on?

Daniel Karlin sits on the board of Definium Therapeutics Inc.

How long has Daniel Karlin served on boards?

Our records show at least 1 month of board service across 1 board, the earliest from 2026.

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.